<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>0</Volume>
      <Issue>0</Issue>
      <PubDate PubStatus="epublish">
        <Year>2026</Year>
        <Month>08</Month>
        <Day>08</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Association between Serum Immune-inflammatory Biomarkers and Target Organ Damage in Patients with Primary Aldosteronism</title>
    <FirstPage>1</FirstPage>
    <LastPage>7</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Liqun</FirstName>
        <LastName>Wang</LastName>
        <affiliation locale="en_US">Department of Endocrinology, The Second Hospital of Yinzhou, Ningbo, China</affiliation>
      </Author>
      <Author>
        <FirstName>Qing</FirstName>
        <LastName>Li</LastName>
        <affiliation locale="en_US">Department of Endocrinology, The Second Hospital of Yinzhou, Ningbo, China</affiliation>
      </Author>
      <Author>
        <FirstName>Fei</FirstName>
        <LastName>Xie</LastName>
        <affiliation locale="en_US">Department of Endocrinology, The Second Hospital of Yinzhou, Ningbo, China</affiliation>
      </Author>
      <Author>
        <FirstName>Xiaojing</FirstName>
        <LastName>Wang</LastName>
        <affiliation locale="en_US">Department of Endocrinology, The Second Hospital of Yinzhou, Ningbo, China</affiliation>
      </Author>
      <Author>
        <FirstName>Lingyan</FirstName>
        <LastName>Ruan</LastName>
        <affiliation locale="en_US">Department of Endocrinology, The Second Hospital of Yinzhou, Ningbo, China</affiliation>
      </Author>
      <Author>
        <FirstName>Qian</FirstName>
        <LastName>Chen</LastName>
        <affiliation locale="en_US">Department of Endocrinology, The Second Hospital of Yinzhou, Ningbo, China</affiliation>
      </Author>
      <Author>
        <FirstName>Endi</FirstName>
        <LastName>Song</LastName>
        <affiliation locale="en_US">Department of Endocrinology, The Second Hospital of Yinzhou, Ningbo, China</affiliation>
      </Author>
      <Author>
        <FirstName>Jiangyong</FirstName>
        <LastName>Lou</LastName>
        <affiliation locale="en_US">Department of Urology, The Second Hospital of Yinzhou, Ningbo, China</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>11</Month>
        <Day>18</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2026</Year>
        <Month>04</Month>
        <Day>21</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">This study aimed to characterize serum immune-inflammatory biomarkers in primary aldosteronism (PA) and to evaluate their correlations and independent associations with target organ damage (TOD) using a propensity score&#x2013;matched cohort design.
This retrospective propensity score&#x2013;matched (PSM) cohort study included 80 patients initially diagnosed with PA (PA group) and 80 matched patients with essential hypertension (EH group) between February 2021 and February 2025. Serum levels of C-reactive protein (CRP), interleukin 6 (IL-6), tumor necrosis factor &#x3B1; (TNF-&#x3B1;), and monocyte chemoattractant protein 1 (MCP-1) were measured. TOD assessment included left ventricular mass index (LVMI), carotid intima-media thickness (IMT), and renal parameters (urinary albumin to creatinine ratio [UACR] and estimated glomerular filtration rate [eGFR]). Group comparisons, correlation analyses, and multivariate logistic regression were performed.
After matching, baseline characteristics were balanced. The PA group had significantly higher levels of all four biomarkers and a higher prevalence of cardiac, vascular, and renal damage. Sensitivity analyses confirmed consistent associations across all organ systems. Elevated IL-6 and CRP strongly correlated with TOD indicators and were independently associated with composite TOD in multivariate analysis (IL-6: OR=1.86; CRP: OR=1.52).
PA is associated with a distinct immune-inflammatory phenotype. IL-6 and CRP are independently associated with multi-system TOD and may serve as practical biomarkers for early risk stratification and timely intervention.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/4663</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/4663/2384</pdf_url>
  </Article>
</Articles>
